Article
Comparison of Clinical Characteristics and Spermatogenesis in CHH Patients Caused by PROKR2 and FGFR1 Mutations.
Reproductive sciences (Thousand Oaks, Calif.) - 1 Nov 2021
Li Shuying, Zhao Yaling, Nie Min, Yang Yufan, Hao Ming, Mao Jiangfeng, Wu Xueyan
Abstract excerpt
A retrospective study was conducted to investigate the effect of gonadotropin or pulsatile gonadotropin-releasing hormone (GnRH) therapy on spermatogenesis in congenital hypogonadotropic hypogonadism (CHH) patients with PROKR2 (prokineticin receptor 2) or FGFR1 (fibroblast growth factor receptor 1) mutations. Clinical features, gonadotropin levels, testicular volume (TV), and sperm concentration in response to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
